title: [New drugs in gastrointestinal oncology. Current status and future directions].
authors.affiliation: Département d'Oncologie Médicale, Centre Alexis Vautrin, Service de Chirurgie Digestive et Générale, CHU de Brabois, Vandoeuvre-les-Nancy.
authors.forename: T
authors.initials: T
authors.lastname: Conroy
authors.forename: B
authors.initials: B
authors.lastname: Paillot
authors.forename: A
authors.initials: A
authors.lastname: Adenis
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077143:Docetaxel; D005467:Floxuridine / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D000077146:Irinotecan; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D000077150:Oxaliplatin; D017239:Paclitaxel / Q000031:analogs & derivatives / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D043823:Taxoids; D005641:Tegafur / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011799:Quinazolines; D043823:Taxoids; D013876:Thiophenes; D005467:Floxuridine; D000077150:Oxaliplatin; D003841:Deoxycytidine; D005641:Tegafur; D000077143:Docetaxel; D014747:Vinblastine; D000069287:Capecitabine; D000077146:Irinotecan; C068874:raltitrexed; D017239:Paclitaxel; D000077235:Vinorelbine; D005472:Fluorouracil; C025034:doxifluridine; D002166:Camptothecin; D000093542:Gemcitabine